Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Jointown Pharmaceutical Group Co., Ltd
  6. News
  7. Summary
    600998   CNE100000W45

JOINTOWN PHARMACEUTICAL GROUP CO., LTD

(600998)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Tranche Update on Jointown Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 16, 2020.

01/05/2021 EST

From September 15, 2020 to December 31, 2020, the company has repurchased 16,834,400 shares, representing 0.92% for CNY 299.93 million. With this, the company has completed the repurchase of 16,834,400 shares, representing 0.92% for CNY 299.93 million under the buyback announced on September 16, 2020.


ę S&P Capital IQ 2021
All news about JOINTOWN PHARMACEUTICAL GROUP CO., LTD
2021Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months En..
CI
2021Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ende..
CI
2021Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter ..
CI
2021Tranche Update on Jointown Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announc..
CI
2021Jointown Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on September 16, 202..
CI
2021JOINTOWN PHARMACEUTICAL : Swiss Logistics Firm Kuehne+Nagel Partners with Jointown to Mana..
MT
2021KUEHNE + NAGEL INTERNATIONAL : Kühne + Nagel International Signs Logistics Deal With China..
MT
2021JOINTOWN PHARMACEUTICAL : ADB, Jointown Sign EUR30 Million Loan to Expand Pharmaceutical D..
AQ
2021Sinovac COVID-19 vaccine unit struggles to add new hires as holiday nears
RE
2021Tranche Update on Jointown Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announc..
CI
More news
Financials
Sales 2021 126 B 19 884 M 19 884 M
Net income 2021 2 841 M 447 M 447 M
Net Debt 2021 2 922 M 460 M 460 M
P/E ratio 2021 8,46x
Yield 2021 4,01%
Capitalization 24 651 M 3 900 M 3 877 M
EV / Sales 2021 0,22x
EV / Sales 2022 0,22x
Nbr of Employees 28 213
Free-Float 36,1%
Chart JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Duration : Period :
Jointown Pharmaceutical Group Co., Ltd Technical Analysis Chart | 600998 | CNE100000W45 | MarketScreener
Technical analysis trends JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 13,48 CNY
Average target price 17,00 CNY
Spread / Average Target 26,1%
EPS Revisions
Managers and Directors
Yi Chang Liu General Manager & Director
Wei He Executive President
Ying Zheng Xu Member-Supervisory Board & Chief Accountant
Xu Min Wen Director
Chang Yun Liu Chairman